HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsPricing
Theme 		Help

New: Introducing the Finviz Crypto Map

Learn More
Market News Stocks News ETF News Crypto News

Apellis Pharmaceuticals, Inc.; Sobi

Contributing Author

Recent Articles by Apellis Pharmaceuticals, Inc.; Sobi

Jun-06
Apellis and Sobi Announce EMPAVELI (pegcetacoplan) Showed Sustained Efficacy at One Year in Phase 3 Study for C3G and Primary IC-MPGN APLS GlobeNewswire
Affiliate • Advertise • Theme Settings • Contact • Blog • Help • Privacy • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.